0001104659-19-060193.txt : 20191106 0001104659-19-060193.hdr.sgml : 20191106 20191105203149 ACCESSION NUMBER: 0001104659-19-060193 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191106 DATE AS OF CHANGE: 20191105 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Centric Brands Inc. CENTRAL INDEX KEY: 0000844143 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 112928178 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-41664 FILM NUMBER: 191194833 BUSINESS ADDRESS: STREET 1: 350 5TH AVENUE STREET 2: 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: 646-582-6000 MAIL ADDRESS: STREET 1: 350 5TH AVENUE STREET 2: 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Differential Brands Group Inc. DATE OF NAME CHANGE: 20160125 FORMER COMPANY: FORMER CONFORMED NAME: JOE'S JEANS INC. DATE OF NAME CHANGE: 20071015 FORMER COMPANY: FORMER CONFORMED NAME: INNOVO GROUP INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Rabin Jason CENTRAL INDEX KEY: 0001756798 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 350 5TH AVE STREET 2: 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10118 SC 13D/A 1 a19-21686_1sc13da.htm SC 13D/A

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 


 

 

 

 

SCHEDULE 13D

 

 

Under the Securities Exchange Act of 1934*
(Amendment No. 2)

 


 

Centric Brands Inc.

(Name of Issuer)

 

Common Stock, par value $0.10 per share

(Title of Class of Securities)

 

15644G 104

(CUSIP Number)

 

Jason Rabin

c/o Centric Brands Inc.

350 5th Avenue, 6th Floor

New York, NY 10118

Tel: (323) 890-1800

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

November 6, 2019

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 

CUSIP No. 15644G 104

 

 

1.

Name of Reporting Person
Jason Rabin

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
PF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
United States

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
3,358,000

 

8.

Shared Voting Power
0

 

9.

Sole Dispositive Power
3,358,000

 

10.

Shared Dispositive Power
0

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
3,358,000

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
5.7% (1)

 

 

14.

Type of Reporting Person (See Instructions)
IN

 


(1) Based upon 58,734,731 shares of common stock, par value $0.10 per share (“Common Stock”) of Centric Brands Inc., a Delaware corporation (the “Issuer”), issued and outstanding as of August 14, 2019, per the Quarterly Report on Form 10-Q filed by the Issuer with the SEC on August 14, 2019.

 

2


 

Explanatory Note

 

This Amendment No. 2 (this “Amendment No. 2”) to Schedule 13D amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission (the “SEC”) on November 8, 2018, as amended on October 8, 2019 (as amended to date, the “Schedule 13D”), on behalf of the Reporting Person with respect to the shares of common stock, par value $0.10 per share (the “Common Stock”), of Centric Brands Inc., a Delaware corporation (the “Issuer”). The Schedule 13D remains in full force and effect, except as specifically amended by this Amendment No. 2.

 

Item 5.         Interest in Securities of the Issuer

 

Item 5 of the Schedule 13D is hereby amended to add the following information:

 

(a) The information set forth on the cover page of this Amendment is incorporated herein by reference. As of the date hereof, Mr. Rabin beneficially owns an aggregate of 3,358,000 shares of the Company’s Common Stock.

 

Excluded from Mr. Rabin’s beneficial ownership are 4,600,000 shares of Common Stock underlying restricted stock units of the Company (“RSUs”) and 500,000 shares of Common Stock underlying performance stock units of the Company (“PSUs”).

 

Each RSU represents a contingent right to receive one share of Common Stock upon vesting. The RSUs are eligible to vest as follows:

 

·                  1,230,000 shares of Common Stock underlying the RSUs will vest in full upon December 31, 2019;

 

·                  1,230,000 shares of Common Stock underlying the RSUs will vest in full upon December 31, 2020;

 

·                  1,640,000 shares of Common Stock underlying the RSUs will vest in full upon December 31, 2021;

 

·                  166,666 shares of Common Stock underlying the RSUs will vest in full upon October 3, 2020;

 

·                  166,667 shares of Common Stock underlying the RSUs will vest in full upon October 3, 2021; and

 

·                  166,667 shares of Common Stock underlying the RSUs will vest in full upon October 3, 2022.

 

33.33% of the PSU will vest on each of December 31, 2019, 2020 and 2021. The PSUs will vest based on the Company’s selling, general and administrative (SG&A) expenses being below a certain target amount for each fiscal year in which the PSUs are scheduled to vest.

 

(b)    The information set forth on the cover page of this Amendment and Item 5(a) hereof is incorporated herein by reference. As of the date hereof, Mr. Rabin holds sole dispositive and voting power over an aggregate of 3,358,000 shares of the Common Stock, consisting of all of the shares identified in Item 5(a) hereof, excluding the RSUs and PSUs identified therein.

 

(c)     The information provided in Items 1-4 hereof is incorporated herein by reference. The following transactions are reflected in the percentages and share amounts reported on the cover page of this Schedule 13D and Item 5(a) and (b) hereof:

 

On October 3, 2019, Mr. Rabin was awarded 710,600 RSUs pursuant to the Company’s 2016 Stock Incentive Plan, as amended (the “2019 Rabin Grant”). This Amendment No. 2 reflects the agreement of Mr. Rabin to void and rescind, nunc pro tunc, 210,600 RSUs previously granted in the 2019 Rabin Grant. 500,000 RSUs granted pursuant to the 2019 Rabin Grant remain outstanding subject to the terms described above.

 

Other than the 2019 Rabin Grant disclosed above, there were no other transfers in the Common Stock effected during the 60 days prior to the date hereof by Mr. Rabin.

 

3


 

(d)       To the best knowledge of the Reporting Person, no person other than the Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Person identified in this Item 5.

 

(e)       Not applicable.

 

4


 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: November 6, 2019

 

 

/s/ Jason Rabin

 

Jason Rabin

 

5